MICHAEL HART: Open Payments
NPI 1548235773 · PEORIA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 20 payments from 8 companies in 2025. Trend: 2023 $372 · 2024 $1,441 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $150 |
| Novo Nordisk Inc | 4 | $97 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Phathom Pharmaceuticals, Inc. | 1 | $30 |
| Edwards Lifesciences Corporation | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $14 |
Products named: Ozempic, VRAYLAR, LINZESS, VOQUEZNA, AIRSUPRA, QULIPTA, CREON, SAPIEN 3 Ultra RESILIA.
Industry payments across AZ — which companies pay providers there.
